Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Tissue that is typically discarded in routine hip replacement operations may offer a rich untapped source of stem cells that could be banked for later use in regenerative medicine, where patients' own cells are used to treat disease or repair failing organs.
This was the implication of a new study led by the University of New South Wales (UNSW) in Australia, published online recently in the journal Stem Cells Translational Medicine.
Study leader Prof. Melissa Knothe Tate and colleagues say, given the tens of thousands of hip replacements performed every year, their findings could have "profound implications" for clinical use.
Currently, to grow new bone or tissue after an infection, injury or the removal of a tumor, if the patient has not preserved stem cells in a cell bank (which is the case for the vast majority of older adults), the stem cells have to come from a donor, or the patient has to undergo surgery to have them harvested from their own bone marrow.
Prof. Knothe Tate explains how their study findings, which now need to be tested clinically, could offer a new source of stem cells for older patients:
"In hip replacement surgery, the femoral head and part of the neck are resected to accommodate the neck of the implant. Typically this tissue is discarded, yet it may provide an untapped source of autologous stem cells for ageing adults who were born a generation too early to benefit from banking of tissues like umbilical cord blood at birth."
For their study, the team collected periosteum derived stem cells (PDCs) from rheumatoid arthritis or osteoarthritis patients aged between 30 and 72 years who had undergone joint replacement surgery. The periosteum is the membrane that covers the outer surface of bone.
When they compared the PDCs with commercially available bone marrow stem cells cultured under the same lab conditions, they found "remarkable similarities."
The PDCs showed no significant differences to the bone marrow stem cells in their ability to differentiate into other cells, regardless of donor age or disease.
The researchers conclude that the periosteum tissue normally discarded in hip replacements offers an "unprecedented and to date unstudied source of stem cells from rheumatoid arthritis or osteoarthritis patients."
Meanwhile, researchers from the US and Japan reported successfully creating embryonic stem cells without embryos. Writing in the journal Nature, they describe how they changed adult stem cells back to their original embryonic state by exposing them to low oxygen and acidic environments.
Written by Catharine Paddock PhD
Copyright: Medical News Today
Not to be reproduced without the permission of Medical News Today.
Arthritic Periosteal Tissue From Joint Replacement Surgery: A Novel, Autologous Source of Stem Cells, Melissa L. Knothe Tate, et al., Stem Cells Trans Med, DOI:10.5966/sctm.2013-0056, published online 29 January 2014. Abstract.
Additional source: University of New South Wales news release 30 January 2014.
Visit our Stem Cell Research category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Paddock, Catharine. "Stem cell source found in tissue discarded in hip replacements." Medical News Today. MediLexicon, Intl., 31 Jan. 2014. Web.
23 Apr. 2014. <http://www.medicalnewstoday.com/articles/271995>
Paddock, C. (2014, January 31). "Stem cell source found in tissue discarded in hip replacements." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/articles/271995.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT is the registered trade mark of MediLexicon International Limited.